Reply to: Need for improvements in reported cost-effectiveness of adalimumab in rheumatoid arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-1250
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Reply to: Need for improvements in reported cost-effectiveness of adalimumab in rheumatoid arthritis ; day:13 ; month:1 ; year:2017 ; pages:1
Zeitschrift für Rheumatologie ; (13.1.2017), 1
- Classification
-
Soziale Probleme, Sozialdienste, Versicherungen
- Keyword
-
Orthopädie
- Creator
-
Gissel, C.
- Contributor
-
Götz, G.
Repp, H.
SpringerLink (Online service)
- DOI
-
10.1007/s00393-016-0256-2
- URN
-
urn:nbn:de:1111-2017021027208
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gissel, C.
- Götz, G.
- Repp, H.
- SpringerLink (Online service)
Other Objects (12)
Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
Cost-effectiveness analysis of Tocilizumab compared to Adalimumab in the treatment of severe active rheumatoid arthritis in Iran
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA
Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis
Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis
Summary of Research: Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA
High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab
Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
Cost-effectiveness analysis of Tocilizumab compared to Adalimumab in the treatment of severe active rheumatoid arthritis in Iran
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA
Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis
Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis
Summary of Research: Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA
High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab
Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
Cost-effectiveness analysis of Tocilizumab compared to Adalimumab in the treatment of severe active rheumatoid arthritis in Iran
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA
Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis
Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis
Summary of Research: Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA